Closing the Women's Health Gap: A $1 Trillion Opportunity for Pharma Innovation

The pharmaceutical industry stands at a critical point in addressing one of healthcare's most significant untapped opportunities. McKinsey Health Institute's groundbreaking research in collaboration with the World Economic Forum reveals that women spend 25% more time in poor health as compared to men; a disparity that, when addressed, could unlock 75 million disability-adjusted life years annually and contribute at least $1 trillion to global GDP.

This keynote will present the five essential pillars of the blueprint for closing the women's health gap. For pharmaceutical leaders, this represents not just a moral imperative but a significant market opportunity. We'll explore how implementing these pillars can drive pharmaceutical innovation, open new market segments, and position companies at the forefront of this healthcare revolution.